Molecular Mechanisms of Ceftaroline Susceptibility Reduction in Methicillin-Resistant Staphylococcus aureus
Ceftaroline is a unique cephalosporin with activity against methicillin resistant Staphylococcus aureus (MRSA). It was approved for clinical use in the USA, Europe and Russian Federation since 2010 for the treatment of the skin and soft tissue infection and community-acquired pneumoniae. In the pres...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Russo |
| Baskı/Yayın Bilgisi: |
LLC "Publishing House OKI"
2020-05-01
|
| Seri Bilgileri: | Антибиотики и Химиотерапия |
| Konular: | |
| Online Erişim: | https://www.antibiotics-chemotherapy.ru/jour/article/view/682 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|